Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» multiple sclerosis
multiple sclerosis
Treating multiple sclerosis with the help of the gut microbiome
Fierce Biotech
Mon, 12/2/19 - 09:58 am
Brigham and Women's
microbiome
microRNA
multiple sclerosis
MS
Patient charity to pay $4M to settle kickback allegations
Beckers Hospital Review
Fri, 11/22/19 - 10:12 am
kickbacks
Medicare
Medicare fraud
MS
multiple sclerosis
Teva Pharmaceutical
Biogen
Novartis
Novartis, Merck KGaA and Biogen: Which new MS drug do doctors like best? You might be surprised
Fierce Pharma
Tue, 11/19/19 - 02:41 pm
MS
multiple sclerosis
physicians
Novartis
Mayzent
Merck KGaA
Mavenclad
Biogen
Vumerity
Vumerity’s $88,000 List Price Not What ‘We Had Hoped,’ National MS Society Says
Multiple Sclerosis News Today
Thu, 11/14/19 - 07:35 pm
Biogen
MS
multiple sclerosis
Vumerity
drug pricing
Tecfidera
Sanofi pays $315 million to settle Lemtrada go-slow claims
Biopharma Dive
Thu, 10/31/19 - 11:56 pm
Sanofi
Genzyme
multiple sclerosis
Lemtrada
Biogen, Alkermes win FDA approval of Tecfidera successor — but can they actually sell it?
Endpoints
Wed, 10/30/19 - 10:13 am
Biogen
Alkermes
FDA
multiple sclerosis
MS
Vumerity
Why People With MS Need Permission from Insurers To Take Life-Saving Drugs. It’s Not The Reason You Think.
Forbes
Mon, 10/28/19 - 10:39 am
MS
multiple sclerosis
patients
insurers
payers
drug pricing
Acorda loses its last shot at protecting its cash cow franchise drug. It’s up to Inbrija now
Endpoints
Mon, 10/7/19 - 11:08 am
Acorda Therapeutics
AMPYRA
multiple sclerosis
Supreme Court
Sanofi breaks into digital therapeutics with mental health app for MS patients
Fierce Pharma
Tue, 09/17/19 - 09:57 am
Sanofi
digital therapeutics
Happyify Health
MS
multiple sclerosis
ECTRIMS: Roche's Ocrevus, given early, cuts wheelchair risk by 42%
Fierce Pharma
Sun, 09/15/19 - 09:59 pm
Roche
Ocrevus
multiple sclerosis
Biogen, wrestling MS rivals, touts 10 year-plus Tecfidera data
Fierce Pharma
Wed, 09/11/19 - 10:26 am
Biogen
Tecfidera
MS
multiple sclerosis
Novartis takes aim at Roche's star MS drug
Reuters
Fri, 08/30/19 - 10:08 am
Novartis
Roche
multiple sclerosis
Arzerra
ofatumumab
Ocrevus
Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in
Fierce Pharma
Thu, 08/29/19 - 08:18 pm
multiple sclerosis
MS
drug pricing
Biogen
Roche
Sanofi
Novartis
Teva Pharmaceutical
Bayer
Multiple sclerosis drug costs skyrocketed for Medicare and patients, study finds
Biopharma Dive
Tue, 08/27/19 - 10:55 pm
drug pricing
MS
multiple sclerosis
Medicare
5 Biggest New Drugs Approved in 2019 So Far
Motley Fool
Tue, 08/13/19 - 11:43 am
drug approvals
FDA
AbbVie
JNJ
Novartis
Pfizer
Skyrizi
psoriasis
Vyndaqel
Zolgensma
SMA
Mayzent
multiple sclerosis
Balversa
metastatic bladder cancer
Tackling the remaining challenges of multiple sclerosis
Pharmaforum
Sat, 08/10/19 - 01:52 pm
Merck KGaA
MS
multiple sclerosis
evobrutinib
Lift off! Celgene MS effort launches hot air balloon to highlight brain health
Fierce Pharma
Mon, 08/5/19 - 11:14 am
Celgene
multiple sclerosis
MS
ozanimod
drug marketing
Upcoming events – Atara and Aslan await validating results
EP Vantage
Fri, 08/2/19 - 10:40 am
Atara
Tab-cel
ATA188
multiple sclerosis
Aslan
varlitinib
The patent play: Biogen gets a PhIII boost for its bit-better take on the blockbuster MS franchise drug Tecfidera
Endpoints
Tue, 07/30/19 - 11:29 am
Biogen
Alkermes
MS
multiple sclerosis
Vumerity
clinical trials
Novartis multiple sclerosis product Gilenya approved in China
Pharmaceutical Business Review
Mon, 07/22/19 - 09:45 am
China
Novartis
multiple sclerosis
Gilenya
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »